Asthma, Heart Failure
Conditions
Keywords
Cost-effectiveness analysis, Colombia
Brief summary
Cost effectiveness analysis of local management of patients diagnosed with heart failure disease compared with an ideal guideline-based management.
Interventions
None listed
Sponsors
AstraZeneca
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Asthma moderate to severe.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incremental cost-effectiveness ratio from using Symbicort as symbicort as Maintenance and Reliever Therapy (SMART) when compared with its competitive alternatives | — |
| To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia | 12 months |
Outcome results
None listed